Your browser doesn't support javascript.
loading
Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
Hoeke, Geerte; Wang, Yanan; van Dam, Andrea D; Mol, Isabel M; Gart, Eveline; Klop, Henk G; van den Berg, Susan M; Pieterman, Elsbet H; Princen, Hans M G; Groen, Albert K; Rensen, Patrick C N; Berbée, Jimmy F P; Boon, Mariëtte R.
Affiliation
  • Hoeke G; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: g.hoeke@lumc.nl.
  • Wang Y; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands; Dept. of Pediatrics, University Medical Center Groningen, Groningen, The Netherland
  • van Dam AD; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Mol IM; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Gart E; The Netherlands Organization of Applied Scientific Research (TNO) - Metabolic Health Research, Gaubius Laboratory, Leiden, The Netherlands.
  • Klop HG; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Berg SM; Dept. of Medical Biochemistry, Subdivision of Experimental Vascular Biology, Academic Medical Center, Amsterdam, The Netherlands.
  • Pieterman EH; The Netherlands Organization of Applied Scientific Research (TNO) - Metabolic Health Research, Gaubius Laboratory, Leiden, The Netherlands.
  • Princen HMG; The Netherlands Organization of Applied Scientific Research (TNO) - Metabolic Health Research, Gaubius Laboratory, Leiden, The Netherlands.
  • Groen AK; Dept. of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands; Dept. of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
  • Rensen PCN; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Berbée JFP; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Boon MR; Dept. of Medicine, Div. of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Atherosclerosis ; 267: 116-126, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29121499

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adipose Tissue, Brown / Atherosclerosis / Atorvastatin / Hypercholesterolemia / Lipoproteins Limits: Animals / Female / Humans Language: En Journal: Atherosclerosis Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adipose Tissue, Brown / Atherosclerosis / Atorvastatin / Hypercholesterolemia / Lipoproteins Limits: Animals / Female / Humans Language: En Journal: Atherosclerosis Year: 2017 Document type: Article